Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acticor Biotech SAS
ALACTCurrent price
0.34 EUR
-0.05 EUR (-12.82%)
Last closed
0.35 EUR
Company
acticor-biotech.com
ISIN
FR0014005OJ5
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
6 930 412 EUR
Yield for 12 month
-93.51 %
1Y
3Y
5Y
10Y
15Y
ALACT
Acticor Biotech SAS operates as a clinical stage biopharmaceutical company that develops drugs for the treatment for acute thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets platelet glycoprotein VI. It's product glenzocimab is in Phase 2/3 clinical trial, as well as completed Phase 1b/2a for the treatment of acute ischemic stroke; and Phase 2/3 clinical trial for treatment of cerebrovascular accidents in emergency situations, as well as completed Phase 2 clinical trial for treating acute respiratory distress syndrome (covid-19). The company has collaboration agreement with the University of Birmingham for Phase 2b clinical trials of glenzocimab in treating heart attacks. The company was incorporated in 2013 and is headquartered in Paris, France. Address: Hôpital Bichat, Paris, France, 75018
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.3 EURP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-722 875 EUR
Last Year
-85 395 EUR
Current Quarter
-715 925 EUR
Last Quarter
–
Key Figures ALACT
1 year
3 years
5 years
10 years
EBITDA
-16 718 474 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-96.9 %
PEG Ratio
–
Return On Equity TTM
-797.48 %
Wall Street Target Price
10.3 EUR
Revenue TTM
1 723 449 EUR
Book Value
-0.4 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
32.8 %
Dividend Yield
–
Gross Profit TTM
317 925 EUR
Earnings per share
-1.53 EUR
Diluted Eps TTM
-1.53 EUR
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALACT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALACT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ALACT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.8824
Price Sales TTM
5.7132
Enterprise Value EBITDA
-5.6759
Price Book MRQ
18.1969
Financials ALACT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALACT
For 52 weeks
0.23 EUR
5.74 EUR
50 Day MA
0.45 EUR
Shares Short Prior Month
–
200 Day MA
2.13 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart